Non-fatal opioid-related overdoses among adolescents in Massachusetts 2012–2014

•In Massachusetts between 2012–2014, 195 adolescents had non-fatal opioid overdose.•Adolescents experiencing non-fatal opioid overdose were mostly female.•They are also less much likely to have been prescribed an opioid in the past year.•Only 8% received any medication for opioid addiction in the ye...

Full description

Saved in:
Bibliographic Details
Published in:Drug and alcohol dependence 2019-01, Vol.194, p.28-31
Main Authors: Chatterjee, Avik, Larochelle, Marc R., Xuan, Ziming, Wang, Na, Bernson, Dana, Silverstein, Michael, Hadland, Scott E., Land, Thomas, Samet, Jeffrey H., Walley, Alexander Y., Bagley, Sarah M.
Format: Article
Language:English
Subjects:
Adolescent
Adolescent Behavior - psychology
Adolescent girls
Adolescents
Adults
Analgesics, Opioid - adverse effects
Buprenorphine
Child
Cohort Studies
Databases, Factual
Drug addiction
Drug overdose
Drug Overdose - diagnosis
Drug Overdose - epidemiology
Drug Overdose - psychology
Female
Humans
Male
Massachusetts - epidemiology
Methadone
Naltrexone
Narcotics
Opioid use disorder
Opioid-Related Disorders - diagnosis
Opioid-Related Disorders - epidemiology
Opioid-Related Disorders - psychology
Opioids
Overdose
Overdoses
Retrospective Studies
Teenagers
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:•In Massachusetts between 2012–2014, 195 adolescents had non-fatal opioid overdose.•Adolescents experiencing non-fatal opioid overdose were mostly female.•They are also less much likely to have been prescribed an opioid in the past year.•Only 8% received any medication for opioid addiction in the year after overdose. Opioid-related overdoses and deaths among adolescents in the United States continue to increase, but little is known about adolescents who experience opioid-related non-fatal overdose (NFOD). Our objective was to describe (1) the characteristics of adolescents aged 11–17 who experienced NFOD and (2) their receipt of medications for opioid use disorder (MOUD) in the 12 months following NFOD, compared with adults. We created a retrospective cohort using six Massachusetts state agency datasets linked at the individual level, with information on 98% of state residents. Individuals entered the cohort if they experienced NFOD between January 1, 2012 and December 31, 2014. We compared adolescents to adults experiencing NFOD, examining individual characteristics and receipt of medications for opioid use disorder (MOUD)—methadone, buprenorphine, or naltrexone. Among 22,506 individuals who experienced NFOD during the study period, 195 (0.9%) were aged 11–17. Fifty-two percent (102/195) of adolescents were female, whereas only 38% of adults were female (P 
ISSN:0376-8716
1879-0046
DOI:10.1016/j.drugalcdep.2018.09.020